Increase your confidence in the purity and safety test results in biotherapeutic manufacturing workflows. When safety is paramount and ensuring regulatory compliance is non-negotiable, genetic analysis of product functionality and purity based on sequencing and fragment analysis can help to mitigate risk and accelerate lot disposition.


Production quality control

Expand opportunities for advancements in quality control with genetic studies on microbial and residual vector impurities and unintended cell line proliferation.

Explore our microbial identification solutions ›


Genotypic sequence drift

Explore changing frequencies of genetic variants in your cultured and stored cells and tissues to identify potential genes associated with resistance to your biopharmaceutical.

Explore our sequencing solutions for candidate loci ›


Targeted locus screening

Track and characterize changing frequencies in biomarkers associated with responses to your biopharmaceutical.


Explore our genotyping solutions ›

Related pages


QualTrak digital experience

Discover QualTrak qPCR and dPCR workflows for mAbs, vaccines, and cell and gene therapies across biopharmaceutical development and manufacturing.

Explore now ›


Monoclonal antibody development

Efficiently develop and characterize recombinant monoclonal antibodies (mAbs) from discovery through clinical trials and manufacturing by incorporating genetic-level analysis into your workflows.

Learn more ›


Innovative support and instrument expertise

We support you with exceptional services, remote tools, training, and OEM expertise we’ve spent 40 years curating.

Download flyer ›

Style Sheet for Global Design System